Mesenchymal Stem Cell and Endothelial Progenitor Cells Coinjection Improves LPS-Induced Lung Injury via Tie2 Activation and Downregulation of the TLR4/MyD88 Pathway

Coinjections of endothelial progenitor cells + mesenchymal stem cells significantly enhanced the survival rate of lipopolysaccharide-induced mice, decreased concentrations of pro-inflammatory cytokines, and increased the level of anti-inflammatory cytokine.